BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29947471)

  • 1. Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.
    Durand CM; Halpern SE; Bowring MG; Bismut GA; Kusemiju OT; Doby B; Fernandez RE; Kirby CS; Ostrander D; Stock PG; Mehta S; Turgeon NA; Wojciechowski D; Huprikar S; Florman S; Ottmann S; Desai NM; Cameron A; Massie AB; Tobian AAR; Redd AD; Segev DL
    Am J Transplant; 2018 Oct; 18(10):2579-2586. PubMed ID: 29947471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
    Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National landscape of HIV+ to HIV+ kidney and liver transplantation in the United States.
    Wilk AR; Hunter RA; McBride MA; Klassen DK
    Am J Transplant; 2019 Sep; 19(9):2594-2605. PubMed ID: 31207040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of deceased organ donors based on HIV, hepatitis B virus, and hepatitis C virus screening test results.
    Theodoropoulos N; Kroll-Desrosiers A; Ison MG
    Transpl Infect Dis; 2020 Aug; 22(4):e13275. PubMed ID: 32144838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices.
    Theodoropoulos N; Jaramillo A; Ladner DP; Ison MG
    Am J Transplant; 2013 Aug; 13(8):2186-90. PubMed ID: 23711196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
    Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, attitudes, and planned practice of HIV-positive to HIV-positive transplantation in US transplant centers.
    Van Pilsum Rasmussen SE; Bowring MG; Shaffer AA; Henderson ML; Massie A; Tobian AAR; Segev DL; Durand CM
    Clin Transplant; 2018 Oct; 32(10):e13365. PubMed ID: 30074638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing Metrics of Organ Procurement Organization Performance in Order to Increase Organ Donation Rates in the United States.
    Goldberg D; Kallan MJ; Fu L; Ciccarone M; Ramirez J; Rosenberg P; Arnold J; Segal G; Moritsugu KP; Nathan H; Hasz R; Abt PL
    Am J Transplant; 2017 Dec; 17(12):3183-3192. PubMed ID: 28726327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant advocacy in the era of the human immunodeficiency virus organ policy equity act.
    Steel JL; Gordon EJ; Dulovich M; Kingsley K; Tevar A; Ganesh S; Brindley E; Sood P; Humar A
    Clin Transplant; 2018 Jul; 32(7):e13309. PubMed ID: 29952035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the Donor Pool: Organ Transplantation from Donors with HIV to Recipients with HIV.
    Nambiar PH; Doby B; Tobian AAR; Segev DL; Durand CM
    Annu Rev Med; 2021 Jan; 72():107-118. PubMed ID: 33502896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results.
    Durand CM; Werbel W; Doby B; Brown D; Desai NM; Malinis M; Price J; Chin-Hong P; Mehta S; Friedman-Moraco R; Turgeon NA; Gilbert A; Morris MI; Stosor V; Elias N; Aslam S; Santos CAQ; Hand JM; Husson J; Pruett TL; Agarwal A; Adebiyi O; Pereira M; Small CB; Apewokin S; Heun Lee D; Haidar G; Blumberg E; Mehta SA; Huprikar S; Florman SS; Redd AD; Tobian AAR; Segev DL
    Am J Transplant; 2020 Feb; 20(2):617-619. PubMed ID: 31675457
    [No Abstract]   [Full Text] [Related]  

  • 12. Zero risk tolerance costs lives: loss of transplantable organs due to human immunodeficiency virus nucleic acid testing of potential donors.
    Shafer TJ; Schkade D; Schkade L; Geier SS; Orlowski JP; Klintmalm G
    Prog Transplant; 2011 Sep; 21(3):236-47; quiz 248. PubMed ID: 21977885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Pruett TL; Clark MA; Taranto SE
    Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipient and kidney graft outcomes of deceased donors with human immunodeficiency virus in the United States.
    Fontana L; Swanson KJ; El-Rifai R; Bregman A; Spong R; Kirchner VA; Pruett T; Jackson S; Riad S
    Transpl Infect Dis; 2023 Aug; 25(4):e14093. PubMed ID: 37432941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving from the HIV Organ Policy Equity Act to HIV Organ Policy Equity in action: changing practice and challenging stigma.
    Doby BL; Tobian AAR; Segev DL; Durand CM
    Curr Opin Organ Transplant; 2018 Apr; 23(2):271-278. PubMed ID: 29432254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of US Public Health Service increased risk deceased donor designation on organ utilization.
    Sapiano MRP; Jones JM; Bowman J; Levi ME; Basavaraju SV
    Am J Transplant; 2019 Sep; 19(9):2560-2569. PubMed ID: 30959569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ utilization from increased infectious risk donors: An observational study.
    L'Huillier AG; Humar A; Payne C; Kumar D
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28981193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor evaluation in the era of HIV-positive organ transplantation: The importance of the infectious diseases specialist.
    Hemmersbach-Miller M; Wood RP; Wolfe CR
    Am J Transplant; 2020 Sep; 20(9):2589-2592. PubMed ID: 32301273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early experiences of independent advocates for potential HIV+ recipients of HIV+ donor organ transplants.
    Bollinger JM; Eno A; Seaman S; Brown D; Van Pilsum Rasmussen SE; Tobian AAR; Segev DL; Durand CM; Sugarman J
    Clin Transplant; 2019 Jul; 33(7):e13617. PubMed ID: 31140611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV+ deceased donor referrals: A national survey of organ procurement organizations.
    Cash A; Luo X; Chow EKH; Bowring MG; Shaffer AA; Doby B; Wickliffe CE; Alexander C; McRann D; Tobian AAR; Segev DL; Durand CM
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29222929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.